Representative Lisa C. McClain (R-Michigan) recently bought shares of Exponent, Inc. NASDAQ: EXPO. In a filing disclosed on September 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Exponent stock on August 13th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
- Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
- Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
- Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
- Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
- Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
- Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
- Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
- Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
- Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.
Exponent Price Performance
Exponent stock traded down $0.82 during midday trading on Friday, hitting $69.34. The company's stock had a trading volume of 1,327,996 shares, compared to its average volume of 424,164. The company has a market cap of $3.50 billion, a price-to-earnings ratio of 34.67 and a beta of 0.94. Exponent, Inc. has a 1-year low of $63.81 and a 1-year high of $115.75. The company has a 50-day moving average price of $71.05 and a two-hundred day moving average price of $75.77.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The company had revenue of $132.87 million for the quarter, compared to analysts' expectations of $130.82 million. During the same period last year, the firm earned $0.57 earnings per share. The business's revenue for the quarter was up 7.3% on a year-over-year basis. Sell-side analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Friday, September 5th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Friday, September 5th. Exponent's dividend payout ratio (DPR) is currently 60.00%.
Hedge Funds Weigh In On Exponent
A number of hedge funds have recently added to or reduced their stakes in EXPO. Mercer Global Advisors Inc. ADV increased its stake in Exponent by 35.2% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 2,429 shares of the business services provider's stock worth $216,000 after acquiring an additional 633 shares during the period. Cetera Investment Advisers increased its stake in Exponent by 3.1% during the 4th quarter. Cetera Investment Advisers now owns 8,903 shares of the business services provider's stock worth $793,000 after acquiring an additional 264 shares during the period. Deutsche Bank AG increased its stake in Exponent by 3.3% during the 4th quarter. Deutsche Bank AG now owns 70,491 shares of the business services provider's stock worth $6,281,000 after acquiring an additional 2,222 shares during the period. Gotham Asset Management LLC bought a new position in Exponent during the 4th quarter worth $260,000. Finally, Millennium Management LLC increased its stake in Exponent by 365.2% during the 4th quarter. Millennium Management LLC now owns 47,464 shares of the business services provider's stock worth $4,229,000 after acquiring an additional 37,260 shares during the period. Institutional investors own 92.37% of the company's stock.
Insider Buying and Selling at Exponent
In other Exponent news, VP Joseph Sala sold 1,595 shares of the firm's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Catherine Corrigan sold 4,905 shares of Exponent stock in a transaction on Monday, September 15th. The shares were sold at an average price of $69.91, for a total value of $342,908.55. Following the completion of the transaction, the chief executive officer owned 82,753 shares in the company, valued at approximately $5,785,262.23. The trade was a 5.60% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,396 shares of company stock valued at $803,636 over the last 90 days. Corporate insiders own 1.60% of the company's stock.
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.